-
公开(公告)号:US11576860B2
公开(公告)日:2023-02-14
申请号:US16427414
申请日:2019-05-31
Inventor: Carlo Giovanni Traverso , Robert S. Langer , Malvika Verma , Niclas Roxhed , Feyisope Eweje , Macy Castaneda
IPC: A61K9/00 , A61K9/20 , A61K31/133 , A61K31/4409 , A61K31/4709 , A61K31/496 , A61K31/4965 , A61K31/65 , A61M25/00 , A61M31/00 , A61B17/50 , A61B17/52 , A61B17/00
Abstract: Drug delivery articles, resident articles, and retrieval systems e.g., for gram-level dosing, are generally provided. In some embodiments, the articles are configured for transesophageal administration, transesophageal retrieval, and/or gastric retention to/in a subject. In certain embodiments, the article includes dimensions configured for transesophageal administration with a gastric resident system. In some cases, the article may be configured to control drug release e.g., with zero-order drug kinetics with no potential for burst release for weeks to months. In some embodiments, the articles described herein comprise biocompatible materials and/or are safe for gastric retention. In certain embodiments, the article includes dimensions configured for transesophageal retrieval. In some cases, the articles described herein may comprise relatively large doses of drug (e.g., greater than or equal to 1 gram).
-
公开(公告)号:US20230027746A1
公开(公告)日:2023-01-26
申请号:US17782355
申请日:2020-12-11
Applicant: Massachusetts Institute of Technology
Inventor: Carlo Giovanni Traverso , Graham Arrick , Torben Sebastian Last
IPC: A61M5/44
Abstract: A device may be configured with a housing having a reservoir and an outlet separated by a heat rupturable membrane. The membrane may serve to separate a material held within the reservoir from the outlet until the membrane is ruptured. The membrane may include a heater configured to selectively rupture the membrane when actuated. The heater may be physically removed and/or thermally insulated from at least one of an environment surrounding the device and the reservoir.
-
公开(公告)号:US20230001083A1
公开(公告)日:2023-01-05
申请号:US17782973
申请日:2020-12-04
Inventor: Carlo Giovanni Traverso , Jason Siu-Wei Li , Rebecca McManus , Seungho Lee , Adam Wentworth , Qianqian Wan
Abstract: Delivery systems and their methods of use for delivering one or more therapeutic compounds to a user are described. A delivery system may include an implantable pump and an external actuator. The implantable pump may include an actuatable portion that may be actuated to dispense a volume of fluid. The external actuator may include a pusher configured to deform skin to engage an actuatable portion of the pump. The external actuator may also include a positioning magnet configured to magnetically attract a portion of the implantable pump such that the external actuator and the pump may be aligned prior to applying force to the portion of the skin between the external actuator and the actuatable portion of the pump.
-
公开(公告)号:US20220287983A1
公开(公告)日:2022-09-15
申请号:US17689314
申请日:2022-03-08
Inventor: Carlo Giovanni Traverso , Ameya R. Kirtane , Robert S. Langer , Hyunjoon KIM , Gary W. Liu , James Byrne , Daniel Reker , Yunhua Shi , Grace Junyue Zhong , Netra Rajesh
IPC: A61K9/51 , C08G63/685 , A61K39/00 , A61K48/00 , A61P35/00
Abstract: The present disclosure provides branched poly(β-amino esters) (PBAEs) of Formula (I) made by reacting primary amines with diacrylates. Further provided herein are compositions comprising the polymers of Formula (I), and methods of using the compositions and polymers as described herein for the treatment of disease. L-(R)n (I)
-
公开(公告)号:US11369574B2
公开(公告)日:2022-06-28
申请号:US16613766
申请日:2018-05-17
Applicant: Massachusetts Institute of Technology , The Brigham and Women's Hospital, Inc. , Novo Nordisk A/S
Inventor: Carlo Giovanni Traverso , Alex G. Abramson , Ester Caffarel Salvador , Niclas Roxhed , Minsoo Khang , Taylor Bensel , Robert S. Langer , Jorrit Jeroen Water , Morten Revsgaard Frederiksen , Bo Uldall Kristiansen , Mikkel Oliver Jespersen , Mette Poulsen , Peter Herskind , Brian Jensen
IPC: A61K9/48 , A61J3/07 , A61K9/00 , A61M5/142 , A61M37/00 , A61M5/20 , A61M5/32 , A61M31/00 , A61M5/158 , A61B5/145 , A61B10/02 , A61N1/32 , A61N1/36 , A61K38/28 , A61N1/05
Abstract: Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject). In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components. In some cases, the tissue interfacing component is associated with a self-actuating component. For example, the self-righting article may comprise a self-actuating component configured, upon exposure to a fluid, to release the tissue interfacing component from the self-righting article. In some cases, the tissue interfacing component may comprise and/or be associated with the pharmaceutical agent (e.g., for delivery to a location internal to a subject).
-
公开(公告)号:US20220193240A1
公开(公告)日:2022-06-23
申请号:US17558867
申请日:2021-12-22
Inventor: Carlo Giovanni Traverso , Jinyao Liu , Robert S. Langer
Abstract: Triggerable hydrogel compositions and related methods are generally disclosed. In some embodiments, the compositions and related methods may be used for medical-related or other applications. For example, the compositions and methods described herein may be useful, for example, in biomedical applications such as articles for (e.g., gastric) retention. In some embodiments, methods for deploying and/or removing an article comprising the composition, such as an article for gastric retention, are provided. The article and/or composition may be removed internally from a subject by, for example, introducing at least one reagent (e.g., one reagent, two reagents) such that at least a portion of the composition disassociates. In certain embodiments, the composition comprises a polymer network comprising two or more interpenetrating polymers. In some cases, a first polymer comprises a first cross-link moiety configured to dissociate upon interaction with a reagent. For example, the composition may be administered to a subject such that it is retained at a location internal (e.g., gastric) to the subject. In some embodiments, a reagent may be administered to the subject (e.g., the subject drinks the reagent) such that the reagent interacts with the composition and at least a first cross-link moiety disassociates. In some embodiments, upon disassociation of one or more cross-link moieties of the polymer network, the composition is no longer retained at the location internal to the subject (e.g., dissociates such that it exits the subject). In some cases, the polymer network is configured (e.g., upon administration of the composition to a subject) such that the composition is retained at the location internal to the subject for greater than or equal to 24 hours.
-
公开(公告)号:US20220142566A1
公开(公告)日:2022-05-12
申请号:US17470942
申请日:2021-09-09
Applicant: Massachusetts Institute of Technology
Inventor: Hen-Wei Huang , James Byrne , Carlo Giovanni Traverso
IPC: A61B5/00 , A61B6/00 , A61B5/1473 , A61K31/4748 , A61M31/00 , A61M5/158
Abstract: Articles, systems, and methods for rapid administration and active pharmaceutical compositions to subjects exposed to radiation and/or toxins are provided by this disclosure. There are currently few interventional technologies to protect against long-term morbidity and mortality from exposure to radiation and chemical warfare. Furthermore, as commercially available technologies such as additive manufacturing and small-scale chemical reactors have become more prevalent, the risk of misuse of such technologies by terrorists and rogue nation states to manufacture nuclear, radiologic, and chemical weapons continues to increase. Articles, systems, and methods described herein combine sensing technologies with drug release components, in order to provide an approach for rapid diagnosis of and response to exposure to radiation and toxic agents.
-
公开(公告)号:US11246829B2
公开(公告)日:2022-02-15
申请号:US16899447
申请日:2020-06-11
Inventor: Andrew Bellinger , Shiyi Zhang , Carlo Giovanni Traverso , Robert S. Langer , Stacy Mo , Tyler Grant , Mousa Jafari , Dean Liang Glettig , Angela DiCiccio , Lowell L. Wood, Jr. , Philip A. Eckhoff
IPC: A61K9/00 , A61K47/58 , A61K47/69 , C08G18/73 , C08G63/08 , C08G18/42 , A61K9/48 , A61K31/357 , A61K31/65 , A61K31/7048 , C08G83/00 , A61K47/32 , C08L33/02 , C08L33/08 , C08L33/14 , A61K47/10 , A61K47/34 , A61K47/40 , A61K47/42 , A61M31/00
Abstract: Residence structures, systems, and related methods are generally provided. Certain embodiments comprise administering (e.g., orally) a residence structure to a subject (e.g., a patient) such that the residence structure is retained at a location internal to the subject for a particular amount of time (e.g., at least about 24 hours) before being released. The residence structure may be, in some cases, a gastric residence structure. In some embodiments, the structures and systems described herein comprise one or more materials configured for high levels of active substances (e.g., a therapeutic agent) loading, high active substance and/or structure stability in acidic environments, mechanical flexibility and strength in an internal orifice (e.g., gastric cavity), easy passage through the GI tract until delivery to at a desired internal orifice (e.g., gastric cavity), and/or rapid dissolution/degradation in a physiological environment (e.g., intestinal environment) and/or in response to a chemical stimulant (e.g., ingestion of a solution that induces rapid dissolution/degradation). In certain embodiments, the structure has a modular design, combining a material configured for controlled release of therapeutic, diagnostic, and/or enhancement agents with a structural material necessary for gastric residence but configured for controlled and/or tunable degradation/dissolution to determine the time at which retention shape integrity is lost and the structure passes out of the gastric cavity. For example, in certain embodiments, the residence structure comprises a first elastic component, a second component configured to release an active substance (e.g., a therapeutic agent), and, optionally, a linker. In some such embodiments, the linker may be configured to degrade such that the residence structure breaks apart and is released from the location internally of the subject after a predetermined amount of time.
-
公开(公告)号:US11202903B2
公开(公告)日:2021-12-21
申请号:US16415417
申请日:2019-05-17
Inventor: Robert S. Langer , Carlo Giovanni Traverso , Alex G. Abramson , David Dellal
Abstract: Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In certain embodiments, the self-righting article a tissue-interfacing components. In some embodiments, each tissue-interfacing component may comprise an electrically-conductive portion configured for electrical communication with tissue and an insulative portion configured to not be in electrical communication with tissue.
-
公开(公告)号:US20210322507A1
公开(公告)日:2021-10-21
申请号:US17363897
申请日:2021-06-30
Applicant: Massachusetts Institute of Technology , The General Hospital Corporation , The Brigham and Women's Hospital, Inc.
Inventor: Robert S. Langer , Carlo Giovanni Traverso , Ameya R. Kirtane , Daniel Cahill , Ganesh Shankar
IPC: A61K38/00 , C12Q1/6886 , A61P35/00 , A61K47/69 , A61K9/00 , A61K9/51 , C12N9/04 , C12N9/10 , C12Q1/6858
Abstract: Provided herein are pharmaceutical compositions for local administration of metabolic inhibitors, methods of locally administering such compositions, and rapid diagnostic methods for identifying mutant allele during the course of a surgical procedure.
-
-
-
-
-
-
-
-
-